Provided By GlobeNewswire
Last update: Mar 25, 2025
GUANGZHOU, China, March 25, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported unaudited financial results for the three months and the year ended December 31, 2024.
Read more at globenewswire.comNASDAQ:BNR (7/24/2025, 11:01:57 AM)
8.48
+0.24 (+2.91%)
Find more stocks in the Stock Screener